The Plasma Proteins Market in the United States – 2021 provides historical sales in units and dollars of all the therapeutic plasma-derived proteins sold in the United States for the full 2021 year by company, as well the sales of recombinant factors and non-factor products. Early events in 2022 are also profiled. It has been published every year since 1974 in June, and has historical data for growth comparisons along with extensive historical commentary to place the current market in the proper context in this large and complex market. It also analyzes recent developments regarding plasma supply (US plasma collections totals and by company) and fractionation, product distribution and new therapeutic plasma proteins. The companies fractionating plasma and selling products in the United States are profiled.

The report is delivered electronically (Excel and pdf files).